← Back to Search

PediQUEST Response for Cancer

N/A
Waitlist Available
Led By Joanne Wolfe, MD
Research Sponsored by Joanne Wolfe, MD, MPH
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks (measured at study entry and 16 weeks)
Awards & highlights

Study Summary

This trial will help to learn whether the new system of care proposed in PediQUEST Response improves quality of life in children, adolescents, and young adults with advanced cancer and their parents.

Eligible Conditions
  • Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks (measured at study entry and 16 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks (measured at study entry and 16 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Child Quality of Life
Secondary outcome measures
Child Quality of Life - subscales
Child Symptom Burden
Child Symptom Burden- subscales
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Usual Cancer CareExperimental Treatment1 Intervention
Will receive the usual cancer care provided at the participating sites Will complete weekly PQ-Surveys (no feedback reports will be generated) Can receive regular palliative care consultations following the site's usual referral procedures Same follow-up (18 weeks)
Group II: PediQUEST ResponseExperimental Treatment1 Intervention
Weekly PediQUEST surveys are automatically assigned to parents and children (if 5 years old or older) and sent 48 hours prior to participant's usual clinic day Once a PediQUEST survey is assigned, automated email reminders/app notifications are sent daily for two days After 48 hours, unanswered or incomplete surveys are auto-submitted PQ-feedback report generated automatically after a PQ Survey is answered A pdf of the report is automatically emailed/available on mobile App to designated recipients Will also receive oncology-PC integrated care through the Response team Duration of follow-up: 18 weeks (2-week run-in period, followed by a 16-week post-randomization follow-up)

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamOTHER
1,583 Previous Clinical Trials
2,279,848 Total Patients Enrolled
Joanne Wolfe, MD, MPHLead Sponsor
Baylor College of MedicineOTHER
1,001 Previous Clinical Trials
6,001,756 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
The PediQUEST Response Intervention Study
Joanne Wolfe, MD, MPH 2018. "The PediQUEST Response Intervention Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03408314.
~28 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top